320 participants
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-24
- Start Date:
- 2026-10-30
- Completion:
- 2028-12-31
Conditions
- Fibrostenotic Crohn's Disease
Interventions
- DRUG
No Results Yet